350 related articles for article (PubMed ID: 8337696)
1. Biliary excretion and enterohepatic cycling of zearalenone in immature pigs.
Biehl ML; Prelusky DB; Koritz GD; Hartin KE; Buck WB; Trenholm HL
Toxicol Appl Pharmacol; 1993 Jul; 121(1):152-9. PubMed ID: 8337696
[TBL] [Abstract][Full Text] [Related]
2. Metabolism of Zearalenone and Its Major Modified Forms in Pigs.
Binder SB; Schwartz-Zimmermann HE; Varga E; Bichl G; Michlmayr H; Adam G; Berthiller F
Toxins (Basel); 2017 Feb; 9(2):. PubMed ID: 28208710
[TBL] [Abstract][Full Text] [Related]
3. Kinetics and metabolism of zearalenone in young female pigs.
Dänicke S; Swiech E; Buraczewska L; Ueberschär KH
J Anim Physiol Anim Nutr (Berl); 2005 Aug; 89(7-8):268-76. PubMed ID: 15972077
[TBL] [Abstract][Full Text] [Related]
4. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide.
Kurebayashi H; Betsui H; Ohno Y
Toxicol Sci; 2003 May; 73(1):17-25. PubMed ID: 12700409
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
Sugimoto T; Hayashi T; Okita A; Morino A
Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
[TBL] [Abstract][Full Text] [Related]
6. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
7. Excretion and biotransformation of ketanserin after oral and intravenous administration in rats and dogs.
Meuldermans W; Hendrickx J; Lauwers W; Swysen E; Hurkmans R; Knaeps F; Woestenborghs R; Heykants J
Drug Metab Dispos; 1984; 12(6):772-81. PubMed ID: 6150829
[TBL] [Abstract][Full Text] [Related]
8. Minimal transmission of zearalenone to milk of dairy cows.
Prelusky DB; Scott PM; Trenholm HL; Lawrence GA
J Environ Sci Health B; 1990 Feb; 25(1):87-103. PubMed ID: 2140383
[TBL] [Abstract][Full Text] [Related]
9. Metabolism and excretion of a novel antianxiety drug candidate, CP-93,393, in Long Evans rats. Differentiation of regioisomeric glucuronides by LC/MS/MS.
Prakash C; Soliman V
Drug Metab Dispos; 1997 Nov; 25(11):1288-97. PubMed ID: 9351906
[TBL] [Abstract][Full Text] [Related]
10. Metabolism and excretion of a new antianxiety drug candidate, CP-93,393, in cynomolgus monkeys: identification of the novel pyrimidine ring cleaved metabolites.
Prakash C; Cui D
Drug Metab Dispos; 1997 Dec; 25(12):1395-406. PubMed ID: 9394030
[TBL] [Abstract][Full Text] [Related]
11. The disposition and pharmacokinetics of ketoconazole in the rat.
Remmel RP; Amoh K; Abdel-Monem MM
Drug Metab Dispos; 1987; 15(6):735-9. PubMed ID: 2893696
[TBL] [Abstract][Full Text] [Related]
12. Metabolism and pharmacokinetics of zearalenone following oral and intravenous administration in juvenile female pigs.
Fleck SC; Churchwell MI; Doerge DR
Food Chem Toxicol; 2017 Aug; 106(Pt A):193-201. PubMed ID: 28552786
[TBL] [Abstract][Full Text] [Related]
13. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
[TBL] [Abstract][Full Text] [Related]
14. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
[TBL] [Abstract][Full Text] [Related]
15. The metabolic disposition of aprepitant, a substance P receptor antagonist, in rats and dogs.
Huskey SE; Dean BJ; Doss GA; Wang Z; Hop CE; Anari R; Finke PE; Robichaud AJ; Zhang M; Wang B; Strauss JR; Cunningham PK; Feeney WP; Franklin RB; Baillie TA; Chiu SH
Drug Metab Dispos; 2004 Feb; 32(2):246-58. PubMed ID: 14744948
[TBL] [Abstract][Full Text] [Related]
16. Absorption and enterohepatic circulation of baicalin in rats.
Xing J; Chen X; Zhong D
Life Sci; 2005 Nov; 78(2):140-6. PubMed ID: 16107266
[TBL] [Abstract][Full Text] [Related]
17. Disposition of the angiotensin II receptor antagonist L-158,809 in rats and rhesus monkeys.
Colletti AE; Krieter PA
Drug Metab Dispos; 1994; 22(2):183-8. PubMed ID: 8013272
[TBL] [Abstract][Full Text] [Related]
18. Biliary excretion and enterohepatic recirculation of morphine-3-glucuronide in rats.
Ouellet DM; Pollack GM
Drug Metab Dispos; 1995 Apr; 23(4):478-84. PubMed ID: 7600915
[TBL] [Abstract][Full Text] [Related]
19. Species differences in the biotransformation of an alpha 4 beta 2 nicotinic acetylcholine receptor partial agonist: the effects of distinct glucuronide metabolites on overall compound disposition.
Shaffer CL; Gunduz M; Ryder TF; O'Connell TN
Drug Metab Dispos; 2010 Feb; 38(2):292-301. PubMed ID: 19910512
[TBL] [Abstract][Full Text] [Related]
20. Influence of a purified diet and route of administration on the metabolism and disposition of estradiol in B6C3F1 mice.
Fullerton FR; Greenman DL; Young JF
Drug Metab Dispos; 1987; 15(5):602-7. PubMed ID: 2891474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
